SVREW vs LFMD

For growth investors, LifeMD, Inc.

(LFMD) is the stronger pick with -8. 7% revenue growth year-over-year, versus -38. 1% for SaverOne 2014 Ltd (SVREW). Analysts rate LifeMD, Inc. (LFMD) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, LifeMD, Inc.

(LFMD) delivered a total return of -45. 8%, compared to -97. 1% for SaverOne 2014 Ltd (SVREW). Over 10 years, the gap is even starker: LFMD returned +220. 7% versus SVREW's -97. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), SaverOne 2014 Ltd (SVREW) is the lower-risk stock at 0.

58β versus LifeMD, Inc. 's 2. 12β — meaning LFMD is approximately 265% more volatile than SVREW relative to the S&P 500. On balance sheet safety, LifeMD, Inc. (LFMD) carries a lower debt/equity ratio of 27% versus 70% for SaverOne 2014 Ltd — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), LifeMD, Inc.

(LFMD) is pulling ahead at -8. 7% versus -38. 1% for SaverOne 2014 Ltd (SVREW). Over a 3-year CAGR, SVREW leads at 55. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

LifeMD, Inc.

(LFMD) is the more profitable company, earning -3. 7% net margin versus -20. 8% for SaverOne 2014 Ltd — meaning it keeps -3. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LFMD leads at -4. 0% versus -1975. 8% for SVREW. At the gross margin level — before operating expenses — LFMD leads at 79. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, LFMD (1.

5% yield) pays a dividend. SVREW does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, SaverOne 2014 Ltd (SVREW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

58)). LifeMD, Inc. (LFMD) carries a higher beta of 2. 12 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SVREW: -97. 1%, LFMD: +220. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SVREW (Technology) and LFMD (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

LFMD pays a dividend while SVREW does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.